DESIGNATING MARCH AS BLEEDING DISORDERS AWARENESS MONTH.
Bill status
in committee
3 of 5 stages cleared
Introduction
Feb 2019
Committee Review
Mar 2019
House Passage
Mar 2019
Senate Passage
Governor
Introduced Feb 7, 2019
Last action Mar 27, 2019
Floor votes · House Mar 27, 2019
How they voted
47–0
Passed · 4 other
Total votes 51
Mar 27, 2019
D
Democratic45
91% Yea
R
Republican5
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
8
Key actions
2
Committee
4
Mar 27, 2019
Committee
Report adopted. referred to the committee(s) on FIN as amended in HD 1 with none voting aye with reservations; none voting no (0) and Representative(s) Creagan, DeCoite, Holt, McKelvey excused (4).
lower
Mar 27, 2019
Committee
Reported from HLT (Stand. Com. Rep. No. 1727) as amended in HD 1, recommending referral to FIN.
lower
Mar 27, 2019
House · Passed
House Vote: pass (47-0-4)
house
Mar 21, 2019
Lower · Passed
The committees on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 5 Ayes: Representative(s) Mizuno, B. Kobayashi, Nakamura, San Buenaventura, Tokioka; Ayes with reservations: none; Noes: none; and 3 Excused: Representative(s) Belatti, Say, Ward.
lower
Mar 7, 2019
Committee
Referred to HLT, FIN, referral sheet 27
lower
Feb 7, 2019
Introduced
Offered
lower
5 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 17
Scope: HI
Hi! I can help you understand HR 17. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline